The State Licensing Authority (SLA), Ayurveda and Unani Services, Uttarakhand, as well as the Central Consumer Protection Authority (CCPA), have taken a firm view on five advertisements placed by Patanjali Ayurveda that promised to treat blood pressure, diabetes, goitre, high lipid levels and glaucoma.
The products are BPgrit, Madhugrit, Thyrogrit, Lipidom and Eyegrit tablets. The SLA asked Divya Pharmacy, the marketing arm of Patanjali Ayurved, on September 7 to remove the advertisements from the media and submit an explanation within a week. The CCPA noted on September 22 that the matter relates to public health and is in violation of the Sections 3 (d) and 106 (1) of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, and Schedule J of the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The authority also forwarded the complaint to the Union Ministry of Ayush for further action.
